Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
Clinical trial NCT05270278 · COMPLETED
Trial details
- NCT number
- NCT05270278
- Sponsor
- Value Outcomes Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-16
- Primary completion
- 2023-03-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.